Amphiregulin Promotes BAX Inhibition and Resistance to Gefitinib in Non-small-cell Lung Cancers

Molecular resistance mechanisms affecting the efficiency of receptor tyrosine kinase inhibitors such as gefitinib in non-small-cell lung cancer (NSCLC) cells are not fully understood. Amphiregulin (Areg) overexpression has been proposed to predict NSCLC resistance to gefitinib and we have establishe...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Busser, Benoît, Sancey, Lucie, Josserand, Véronique, Niang, Carole, Favrot, Marie C, Coll, Jean-Luc, Hurbin, Amandine
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2009
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2839434/
https://ncbi.nlm.nih.gov/pubmed/19826406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2009.226
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires